Eliminating TSC1 (tuberous sclerosis 1), a mTORC1 inhibitor, to constitutively activate mTORC1 in pre-osteoblasts stimulated osteosclerosis and CXCL12 secretion, thus exacerbating OA. Here, TSC1 is linked to osteosclerosis.